Stocktoria
FILANA THERAPEUTICS, INC. FLNA
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2000-07-14
FILANA THERAPEUTICS, INC. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2022 |
|---|---|---|---|---|---|
| R&D expense | $26.6M | $69.6M | $89.4M | $68.0M | — |
| Operating income | -$95.4M | -$141.4M | -$106.0M | -$80.0M | — |
| Income tax | $0 | $0 | — | — | $0 |
| Net income | -$91.0M | -$24.3M | -$97.2M | -$76.2M | — |
| EPS (diluted) | $-1.88 | $-1.46 | $-2.32 | $-1.90 | — |
| Operating cash flow | -$32.3M | -$116.9M | -$82.0M | -$77.5M | — |
| Free cash flow | -$32.8M | -$117.0M | -$82.4M | -$80.2M | — |
| Cash & equivalents | $95.5M | $128.6M | $121.1M | $201.0M | $174.7M |
| Total assets | $118.4M | $157.5M | $151.7M | $234.8M | $207.3M |
| Total liabilities | $44.0M | $11.8M | $14.2M | $7.3M | $8.6M |
| Shareholders' equity | $74.4M | $145.7M | $137.5M | $227.5M | $198.7M |
Source: SEC EDGAR filings · CIK 0001069530 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.